Cholinesterase inhibitors, neuromuscular blocking drugs and perioperative memory enhancement [6]

Anesthesiology

Volumn 101, Issue 6, 2004, Pages 1483-1484

  Fodale, Vincenzo ^a   Tescione, Marco ^b   Praticò, Caterina ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; CISATRACURIUM; DONEPEZIL; GALANTAMINE; LAUDANOSINE; NEUROMUSCULAR BLOCKING AGENT; PHYSOSTIGMINE; RIVASTIGMINE;

ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; COGNITION; CONSCIOUSNESS; DRUG EFFECT; HUMAN; LETTER; MEMORY; MEMORY DISORDER; PERIOPERATIVE PERIOD; PRIORITY JOURNAL;

EID: 9444237928     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200412000-00045     Document Type: Letter

References (18)

1. Ghoneim MM: Drugs and human memory (part 2). Clinical, theoretical, and methodologic issues. ANESTHRSIOLOGY 2004; 100:1277-97
2. Boccia MM, Acosta GB, Baratti CM: Memory improving actions of gabapentin in mice: Possible involvement of central muscarinic cholinergic mechanism. Neurosci Lett 2001; 311:153-6
3. Nordberg A, Svensson AL: Cholinesterase inhibitors in the treatment of Alzheimer's disease: A comparison of tolerability and pharmacology. Drug Saf 1998; 19:465-80
4. Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thai LJ, Whitehouse PJ, DeKosky ST, Cummings JL: Practice parameter: Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1154-66
5. Knopman DS, Morris JC: An update on primary drug therapies for Alzheimer disease. Arch Neurol 1997; 54:1406-9
6. Meuret P, Backman SB, Bonhomme V, Plourde G, Fiset P: Physostigmine reverses propofol-induced unconsciousness and attenuation of the auditory steady state response and bispectral index in human volunteers. ANESTHESIOLOGY 2000; 93:708-17
7. Plourde G, Chartrand D, Fiset P, Font S, Backman SB: Antagonism of sevoflurane anaesthesia by physostigmine: Effects on the auditory steady-state response and bispectral index. Br J Anaesth 2003; 91:583-6
8. Metherate R, Cox CL, Ashe JH: Cellular bases of neocortical activation: Modulation of neural oscillations by the nucleus basalis and endogenous acetylcholine. J Neurosci 1992; 12:4701-11
9. Llinas RR, Pare D: Commentary of dreaming and wakefulness. Neuroscience 1991; 44:521-35
10. Hill GE, Stanley TH, Sentker CR: Physostigmine reversal of postoperative somnolence. Can Anaesth Soc J 1977; 24:707-11
11. Fodale V, Santamaria LB: Different actions of sevoflurane and propofol on central nicotinic receptors may explain differences in hypnotic antagonism by Cholinesterase inhibitors. Br J Anaesth 2004; 92:773-4
12. Andoh T: Effects of general anesthetics on neuronal nicotinic acetylcholine receptors and their roles in the mechanism of anesthesia. Masui 2001; 50:1072-84
13. Addy NA, Nakijama A, Levin ED: Nicotinic mechanisms of memory: effects of acute local DHbetaE and MLA infusions in the basolateral amygdala. Brain Res Cogn Brain Res 2003; 16:51-7
14. Fodale V, Santamaria LB: Laudanosine, an atracurium and cisatracurium metabolite. Eur J Anaesth 2002; 19:466-73
15. Tassonyi E, Fathi M, Hughes J, Chiodini F, Bertrand D, Muller D, Fuchs-Buder T: Cerebrospinal fluid concentrations of atracurium, laudanosine and vecuronium following clinical subarachnoid hemorrhage. Acta Anaesthesiol Scand 2002; 46:1236-41
16. Fodale V, Santamaria LB: Drugs of anesthesia, central nicotinic receptors and post-operative cognitive dysfunction. Acta Anaesthesiol Scand 2003; 47:1180
17. Fodale V, Santamaria LB: The inhibition of central nicotinic nAch receptors is the possible cause of prolonged cognitive impairment after anesthesia. Anesth Analg 2003; 97:1207
18. Fodale V, Praticò C, Santamaria LB: Drugs of anesthesia, central nicotinic receptors and Parkinson's disease. Parkinsonism Relat Disord 2004; 10:189-90